Overexpression of Salusin-α Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model

Table 2

Blood lipid biochemical parameters in different groups.

Group	P	RP	EP	ERP	HFD	S	OD
TG (mmol/L)	3.45 ± 0.72	3.35 ± 0.74	3.56 ± 0.52	3.63 ± 0.64	3.43 ± 0.82	3.12 ± 0.56	1.12 ± 0.64
TC (mmol/L)	0.83 ± 0.91	3.68 ± 0.53	2.54 ± 0.42	2.42 ± 0.37	2.63 ± 0.35	2.61 ± 0.33	1.63 ± 0.86
HDL-C (mmol/L)	1.42 ± 0.12	0.21 ± 0.08	0.35 ± 0.06	0.34 ± 0.07	0.37 ± 0.09	0.36 ± 0.10	0.52 ± 0.14
LDL-C (mmol/L)	0.37 ± 0.08	2.64 ± 0.76	1.54 ± 0.55	1.64 ± 0.72	1.44 ± 0.52	1.54 ± 0.62	0.78 ± 0.57
ApoAI (g/L)	0.43 ± 0.06	0.10 ± 0.02	0.16 ± 0.02	0.17 ± 0.02	0.16 ± 0.01	0.15 ± 0.02	0.18 ± 0.04
ApoB (g/L)	0.03 ± 0.01	0.13 ± 0.03	0.11 ± 0.03	0.12 ± 0.01	0.14 ± 0.02	0.13 ± 0.02	0.05 ± 0.01
Lp (α) (mg/L)	187 ± 30.7	178 ± 27.6	189 ± 30.3	187 ± 28.5	188 ± 27.9	191 ± 30.2	193 ± 28.5

Variables are presented as means ± standard deviations. P, pc-salusin-α plasmid group; RP, RNA plasmid si-salusin-α group; EP, empty plasmid group; ERP, empty RNA plasmid group; HFD, high-fat diet group; S, SonoVue group; OD, ordinary diet group; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein A; ApoB, apolipoprotein B; and Lp(α), lipoprotein alpha. , .